deltatrials
Terminated PHASE2 INTERVENTIONAL 2-arm NCT01432080

Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant

Does Increasing Immunosuppression Prevent Transplant-associated Lung-disease Triggered by Viral Respiratory Tract Infection Following Allogeneic Stem Cell Transplant? A Pilot Study

Sponsor: Maisonneuve-Rosemont Hospital

Conditions Bronchiolitis Obliterans Cryptogenic Organizing Pneumonia Lung Diseases, Interstitial Respiratory Tract Infections
Interventions Azithromycin Montelukast Prednisone Symbicort
Updated 8 times since 2017 Last updated: Oct 13, 2021 Started: Sep 30, 2011 Primary completion: Dec 31, 2012 Completion: Dec 30, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Not meeting recruitment targets

Other terminated trials from Maisonneuve-Rosemont Hospital

See all terminations from Maisonneuve-Rosemont Hospital

Other Bronchiolitis Obliterans trials with similar outcome

Browse all Bronchiolitis Obliterans trials

This PHASE2 trial investigates Bronchiolitis Obliterans and Cryptogenic Organizing Pneumonia and is currently terminated or withdrawn. Maisonneuve-Rosemont Hospital leads this study, which shows 8 recorded versions since 2011 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotSuspended~Feb 2017 – ~Sep 2017 · 7 months · monthly snapshotSuspended~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Nov 2021 · 10 months · monthly snapshotTerminated~Nov 2021 – ~Jul 2024 · 32 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Nov 2021 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Jan 2021 — Nov 2021 [monthly]

    Terminated PHASE2

  5. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE2

▶ Show 3 earlier versions

  1. Sep 2017 — Jun 2018 [monthly]

    Terminated PHASE2

    Status: Suspended → Terminated

  2. Feb 2017 — Sep 2017 [monthly]

    Suspended PHASE2

  3. Jan 2017 — Feb 2017 [monthly]

    Suspended PHASE2

    First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Maisonneuve-Rosemont Hospital
  • The Canadian Blood and Marrow Transplant Group
Data source: Maisonneuve-Rosemont Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations